You are here : 首页 > 新闻 > 所有新闻 > Sustainable energies and biomedical engineering degrees m...
所有新闻
Sustainable energies and biomedical engineering degrees make their first appearance on the ESIGELEC programme
Published the 07-12-2009ESIGELEC is currently trying to offer future engineers courses which will be relevant to new sectors of industry by launching two new major areas in the second and third years of its Engineering cycle - Sustainable Development & Energy and Biomedical Engineering.
These transversal majors of 340 hours each provide students with solid scientific and technical knowledge and also the management skills required to prepare future engineers for working in senior supervisory positions. They will also help them to become business developers or start up businesses in future sectors such as sustainable energies and biomedical engineering.
In order to effectively design and manage the course programmes, ESIGELEC has created partnerships with well known businesses in the sectors concerned, top level scientific and educational establishments, and the Haute Normandie regional energy sector.
Sustainable Development and Energy major - in association with EDF, VINCI ENERGIES, the Haute Normandie Regional Council and the University of Rouen
In view of the dwindling use of fossil fuels and the environmental challenges facing the planet, scientific research is now focusing on energy efficiency techniques with the aim of reducing energy consumption by buildings, industry and transport. It is also concentrating on developing methods of producing electricity which emits little or no greenhouse gases along with ways of preserving raw materials.
The Sustainable Development and Energy major aims to provide engineers with the training necessary to master the technologies involved in energy systems, to carry out a diagnosis of the requirements of a private or industrial facility, and propose solutions which balance energy efficiency, environmental impact and economic profitability. They will also learn about standardization, regulation, fiscal issues and market strategies which apply to the energy sector.
For this programme, ESIGELEC is pleased to be able to rely on the support of the Haute Normandie region’s energy sector. The school has effectively joined this hub of excellence created by local government and large energy producing companies in the region (EDF, large oil companies). As one of the biggest energy sectors in France, the Haute Normandie region employs more than 20,000 people directly or indirectly.
The partners and members of the programme’s steering committee include EDF, RENOUVELAB, ECOFYS, ENOLYA, VINCI ENERGIES, ALCA TORDA Applications, the University of Rouen, and the Haute Normandie Regional Council.
Different career opportunities include research engineer, consultant engineer and R&D engineer, in industry, the construction trade, renewable energy sectors (solar, wind, biomass, energy efficiency, fuel cells, etc), energy production (nuclear power, hydropower, electricity), the environment, starting businesses in France, or elsewhere in the world for international students.
Biomedical Engineering major – in association with ORKYN, NXP/OPHTIMALIA, QUIDD, INSERM, SEINARI and Rouen University Hospital
Biomedical engineering is the application of engineering principles and technologies to the field of medicine and the living being. Applications include all medical instrumentation involved in the treatment and care of patients. Because of technological advances in electronics and IT, this sector is booming and requires new skills to deal with recent developments and requirements.
The Biomedical Engineering major aims to train engineers to design, produce and maintain devices which enable optimal medical activity (equipment, instruments, apparatus, software, etc) and to be able to market these devices and train people to use them.
Career opportunities are numerous and include biomedical engineer in a hospital environment, research engineer, commercial engineer, business start-ups, etc.
The partners and members of the programme’s steering committee include ORKYN, NXP/OPHTIMALIA, QUIDD, INSERM, SEINARI, and Rouen University Hospital.
Back
